Ardea Biosciences (RDEA) Reports Positive Results from Phase 1 Study of RDEA594 and Phase 2a Study of RDEA806
Tweet Send to a Friend
Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
